Our Business Model

iGuard was created by professionals with decades of experience in healthcare market research, clinical drug development, and drug safety. Initially funded by Quintiles Transnational, the leading provider of clinical research services, the purpose of iGuard is to promote better communication and research about drug safety.

We believe that the patient can play an important role in improving drug safety. Today, public and private organizations spend millions of dollars on drug safety research and risk management programs—often with disappointing results. At iGuard, we feel strongly that connecting patients and researchers will allow us to do better, faster and more cost-effective research.

To cover the cost of operating our efficiently structured service, iGuard will soon begin to offer customized drug safety studies, risk management programs, and other research programs. We are confident that these research opportunities will cover the cost of our communication network and help improve the safety of medicines.

To cover the cost of operating our efficiently structured service, iGuard has begun to leverage the feedback of our members to inform clinical trial design, risk management programs, and adherence programs among other activities. We are confident that these research activities will cover the cost of our communication network and help to speed drug development and improve the safety of medicines.

Register today to get personalized personalised safety information and begin sharing feedback about your medications.